ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $773,117 | -17.8% | 6,322 | -14.7% | 0.07% | -15.3% |
Q2 2023 | $940,520 | -37.1% | 7,408 | -36.0% | 0.08% | -40.6% |
Q1 2023 | $1,495,414 | -6.0% | 11,578 | -4.5% | 0.14% | -11.2% |
Q4 2022 | $1,591,104 | +38.5% | 12,119 | +23.4% | 0.16% | +25.8% |
Q3 2022 | $1,149,000 | +48.6% | 9,823 | +49.5% | 0.13% | +56.1% |
Q2 2022 | $773,000 | -12.8% | 6,571 | -3.3% | 0.08% | -2.4% |
Q1 2022 | $886,000 | -19.5% | 6,796 | -5.8% | 0.08% | -16.0% |
Q4 2021 | $1,101,000 | -4.3% | 7,213 | +1.3% | 0.10% | -12.3% |
Q3 2021 | $1,151,000 | +7.2% | 7,117 | +8.4% | 0.11% | +3.6% |
Q2 2021 | $1,074,000 | +2.9% | 6,565 | -5.3% | 0.11% | -2.7% |
Q1 2021 | $1,044,000 | +5.7% | 6,931 | +6.2% | 0.11% | -0.9% |
Q4 2020 | $988,000 | +19.6% | 6,525 | +7.0% | 0.11% | +2.7% |
Q3 2020 | $826,000 | +52.1% | 6,097 | +53.6% | 0.11% | +42.3% |
Q2 2020 | $543,000 | +77.5% | 3,970 | +39.8% | 0.08% | +52.9% |
Q1 2020 | $306,000 | -51.9% | 2,839 | +38.4% | 0.05% | -47.4% |
Q2 2017 | $636,000 | – | 2,052 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |